MasimoMASI 85 Days Payable is 57.33 as of Mar. 2026, which is 1% below its 10-year median of 57.65. GuruFocus rates MASI with a GF Score™ of 85/100 and a GF Value™ of $170.14 (Fairly Valued). The stock has 9 warning signs investors should review. Among 795 Medical Devices & Instruments companies, Masimo ranks better than 50.94% on this metric.
Masimo's average Accounts Payable for the
three
months ended in Mar. 2026 was $96 Mil. Masimo's Cost of Goods Sold for the
three
months ended in Mar. 2026 was $153 Mil.
Hence, Masimo's Days Payable for the
three
months ended in Mar. 2026 was 57.33.
The historical rank and industry rank for Masimo's Days Payable or its related term are showing as below:
MASI'
s Days Payable Range Over the Past 10 Years
Min: 46.35 Med: 57.65 Max: 189.09
Current: 69.82
During the past 13 years, Masimo's highest Days Payable was 189.09. The lowest was 46.35. And the median was 57.65.
MASI's Days Payable is ranked better than 50.94% of 795
companies
in the Medical Devices & Instruments industry
Industry Median: 67.87
vs MASI: 69.82
Masimo's Days Payable
declined
from Mar. 2025 (83.94) to Mar. 2026 (57.33).
It may suggest that Masimoaccelerated paying its suppliers.
Masimo Days Payable Related Terms
Masimo Days Payable Historical Data
* Premium members only.
The historical data trend for Masimo's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Masimo's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Masimo Days Payable vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Masimo's Days Payable distribution charts can be found below:
* The bar in red indicates where Masimo's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Masimo's Days Payable for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Masimo (MASI) has a Days Payable of 57.33 as of Mar. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Masimo and its competitors. This is near median its historical median of 57.65. Over the past decade, Masimo's Days Payable has ranged from 46.35 to 189.09. According to the industry distribution chart, Masimo ranks #390 out of 795 companies in the Medical Devices & Instruments industry, placing it in the top 49.1%.
Is Masimo's Days Payable too high?
Masimo's current Days Payable of 57.33 is near median its 10-year median of 57.65. Over the past 10 years, this metric has ranged from a low of 46.35 to a high of 189.09. The Medical Devices & Instruments industry median Days Payable is 67.87. Masimo's value of 57.33 is 15.5% below this industry median. Based on the distribution chart, Masimo ranks #390 out of 795 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Masimo has a GF Score™ of 85/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Masimo's Days Payable compare to BRKR and PODD?
According to the Medical Devices & Instruments industry distribution chart, Masimo ranks #390 out of 795 companies for Days Payable. This puts Masimo in the upper half of its industry. The industry median Days Payable is 67.87. Masimo's value of 57.33 is 15.5% below this benchmark. Historically, Masimo's own Days Payable has ranged from 46.35 to 189.09 over the past decade. While the company's 10-year median is 57.65 vs. the industry median of 67.87, Masimo has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Medical Devices & Instruments company?
The median Days Payable among Medical Devices & Instruments companies is 67.87, based on 795 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Masimo's current Days Payable of 57.33 is 15.5% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Masimo and its competitors. For the Medical Devices & Instruments industry, the median Days Payable is 67.87 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Masimo's current Days Payable is 57.33, which is near median its own 10-year median of 57.65. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Masimo stock overvalued right now?
Based on GuruFocus' analysis, Masimo (MASI) is currently considered Fairly Valued. The stock's GF Value™ is $170.14, compared to a current price of $179.95 — trading 5.8% above its estimated fair value. The current Days Payable is 57.33, which is near median its 10-year median of 57.65 and 15.5% below the Medical Devices & Instruments industry median of 67.87. Masimo's overall GF Score™ is 85/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Masimo (MASI), the current Days Payable is 57.33 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Masimo (MASI) Overvalued in 2026?
Based on GuruFocus' analysis, Masimo stock appears to be overvalued.
The current stock price of $179.95 is trading 5.8% above its estimated GF Value™ of $170.14.
GuruFocus considers Masimo to be Fairly Valued.
Key valuation signals for MASI:
Days Payable: 57.33 (near median its 10-year median of 57.65)
GF Value™: $170.14 vs. price of $179.95 (5.8% above fair value)
Industry Position: 15.5% below the Medical Devices & Instruments median (#390 of 795)
No single metric tells the full story. See the MASI stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Masimo Corp is a medical technology company. The company oepates in single segment namely Healthcare. The healthcare business segment is a key revenue driver, develops, manufactures, and markets a variety of noninvasive patient monitoring technologies, hospital automation and connectivity solutions, remote monitoring devices and consumer health products. The company sells its products to hospitals, emergency medical service providers, home care providers, physician offices, veterinarians, and others.
85GF Score
Get the complete analysis for MASI
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MASI has been successfully added to your 
